HOME > ARCHIVE
ARCHIVE
- Dainippon Sumitomo, Aska Pharm., Mediceo Paltac Inaugurated on Oct. 1
October 10, 2005
- SELF-MEDICATION NEWS IN BRIEF
October 10, 2005
- Dainippon Sumitomo Starts Marketing under New System
October 10, 2005
- Daiichi Sankyo Sets Out Forecasting Sales of \894.5 Bil. in FY2005
October 10, 2005
- Cancer Patients' Groups Go into Action
October 3, 2005
- Is DWIBS Superior to PET?
October 3, 2005
- TOPICS 2 articles
October 3, 2005
- The Reporter's Eye: 11
October 3, 2005
- Eliminate Regional Differences in the Level of Treatment
October 3, 2005
- Nu-lotan Safe and Effective for at Least 42 Months: Interim Results of J-HEALTH Study
October 3, 2005
- The Reporter's Eye: 10
October 3, 2005
- Pramipexole Effective in Improving Restless Leg Syndrome: NBI
October 3, 2005
- Actos Poised for Sharp Growth in Wake of PROactive Study: Takeda
October 3, 2005
- R&D NEWS IN BRIEF
October 3, 2005
- Global Bioventure Forum
October 3, 2005
- Medical Fees Likely to Be Cut in Next Revision in 2006: Prof. Niki
October 3, 2005
- Mediceo HD, Mitsubishi Corp. Tie-up in Medical Services Business
October 3, 2005
- Prevention Is More Important in Ensuring Safe Use of Drugs: SJP Seminar
October 3, 2005
- Kyoso Mirai Group to Establish Administrative Work Center
October 3, 2005
- How to Prepare CTD Explained at Joho Kiko Seminar
October 3, 2005
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
